ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $148M

      Shares

      2.8M

      % of Portfolio

      0.41%

      Average Buy Price

      $191

      Avg closing price
      Price range

      42 Ron Baron Bio-Techne Trades

      Ron Baron acquired 2.8M Bio-Techne shares worth $148M. That's 0.41% of their equity portfolio (46th largest holding). The investor owns 1.72% of the outstanding Bio-Techne stock. The first Bio-Techne trade was made in Q4 2014. Since then Ron Baron bought shares thirteen more times and sold shares on 28 occasions. The investor's estimated purchase price is $533M, resulting in a loss of 72%.

      Avg closing price
      Price range
      Sold 14.7% shares (-481k shares) Q2 2025
      Avg closing price $50.16
      Price range $46.66 - $58.38
      Sold 20.8% shares (-861k shares) Q1 2025
      Avg closing price $67.98
      Price range $58.47 - $78.75
      Sold 6.9% shares (-309k shares) Q4 2024
      Avg closing price $73.50
      Price range $66.37 - $78.17
      Sold 6.9% shares (-331k shares) Q3 2024
      Avg closing price $75.07
      Price range $70.96 - $82.35
      Sold 4.4% shares (-222k shares) Q2 2024
      Avg closing price $73.60
      Price range $62.12 - $84.15
      Sold 6.6% shares (-354k shares) Q1 2024
      Avg closing price $71.55
      Price range $65.98 - $77.09
      Sold 0.4% shares (-24k shares) Q4 2023
      Avg closing price $65.87
      Price range $52.83 - $78.22
      Sold 0.1% shares (-4.52k shares) Q3 2023
      Avg closing price $79.00
      Price range $67.52 - $89.42
      Increased shares by 0.0% (+982 shares) Q2 2023
      Avg closing price $80.38
      Price range $73.76 - $85.98
      Sold 2.5% shares (-140k shares) Q1 2023
      Avg closing price $77.07
      Price range $71.62 - $86.62
      Increased shares by 286.7% (+4.09M shares) Q4 2022
      Avg closing price $230.67
      Price range $80.67 - $352.29
      Sold 1.7% shares (-24.3k shares) Q3 2022
      Avg closing price $345.64
      Price range $282.54 - $391.85
      Sold 1.2% shares (-17.7k shares) Q2 2022
      Avg closing price $374.87
      Price range $322.67 - $449.65
      Sold 0.9% shares (-13.8k shares) Q1 2022
      Avg closing price $412.68
      Price range $353.85 - $487.79
      Sold 0.7% shares (-10.9k shares) Q4 2021
      Avg closing price $490.35
      Price range $456.15 - $525.06
      Sold 0.3% shares (-4.12k shares) Q3 2021
      Avg closing price $486.80
      Price range $444.87 - $538.88
      Increased shares by 0.2% (+2.71k shares) Q2 2021
      Avg closing price $421.02
      Price range $387.35 - $450.26
      Increased shares by 0.1% (+1.79k shares) Q1 2021
      Avg closing price $364.91
      Price range $314.62 - $411.00
      Sold 0.1% shares (-1.76k shares) Q4 2020
      Avg closing price $289.67
      Price range $246.90 - $321.87
      Sold 1.5% shares (-23.2k shares) Q3 2020
      Avg closing price $260.20
      Price range $232.22 - $282.96

      News about Bio-Techne Corp and Ron Baron

      Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3

      Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3

      Baron Funds, an investment management company, released its ¡°Baron Health Care Fund¡± third quarter 2023 investor letter. A copy of the same can be downloaded...

      Insider Monkey Insider Monkey, almost 2 years ago
      Ron Baron Comments on Bio-Techne

      Ron Baron Comments on Bio-Techne

      Guru stock highlight Check out Ron Baron Stock Picks ? Download GuruFolio Report of Ron Baron (Updated on 11/08/2022) Related Stocks: TECH ,

      GuruFocus GuruFocus, almost 3 years ago
      Baron Funds: ¡°Bio-Techne (TECH) Can Still Generate Strong Revenue Growth¡±

      Baron Funds: ¡°Bio-Techne (TECH) Can Still Generate Strong Revenue Growth¡±

      Baron Funds, an asset management firm, published its ¡°Baron Health Care Fund¡± first quarter 2022 investor letter ¨C a copy of which can be downloaded here.

      Insider Monkey Insider Monkey, about 3 years ago
      Heres Why Baron Funds Remains Confident in Bio-Techne Corporation (TECH)

      Heres Why Baron Funds Remains Confident in Bio-Techne Corporation (TECH)

      No summary available.

      Insider Monkey Insider Monkey, about 4 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×